Who’s really in charge when the US health system has no leaders?

The US government has quietly blocked its top disease experts from talking directly to the World Health Organization. Instead, small groups of researchers can only listen during WHO meetings—like students in a classroom who can’t ask questions. Any ideas they have must go through layers of bureaucracy first. This rule has been in place since an outbreak of hantavirus and was only slightly relaxed when Ebola cases surged in Africa. Behind the scenes, the National Institute of Allergy and Infectious Diseases—once led by Dr. Anthony Fauci—has been without a permanent leader for months. The acting director just quit, leaving the agency leaderless. Meanwhile, key health positions across the country sit empty. The surgeon general role? Never filled. The CDC director? Gone in less than a month. The FDA commissioner? Just left too. That’s like running a hospital with no boss.This leadership crisis isn’t just about empty chairs. It’s about broken connections. The US used to have teams on the ground in Africa tracking diseases like Ebola. Those teams were funded by USAID—until the agency was dismantled last year. Now, when warnings arise, there’s no clear path to report them. One health official compared it to a game of telephone where the message never reaches the right person. Some argue the WHO’s slow response to Ebola proves the US was right to step back. But others say cutting ties only makes things worse. The WHO recently raised the risk level of the Ebola outbreak in Congo, yet the US has no direct way to share or receive critical updates. Meanwhile, travelers from Africa face extra checks at three US airports. One American doctor caught Ebola abroad is being treated in Germany. No cases have reached the US yet—but the system is scrambling. The bigger picture? A health leadership vacuum at home and less influence abroad. When crises hit, quick action matters. Without leaders or clear communication, the US risks being late to the game—again.